MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$832,424
EPS
-$0.47
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2025-09-30
Accounting and audit fees
145,579
Research and development
273,229
Legal fees
121,868
Consulting fees
73,243
Salaries and wages
340,030
General and administrative - other
159,915
Total operating expenses
1,113,864
Loss from operations
-1,113,864
Interest expenses/amortization of discount
34,337
Change in fair value of derivative liabilities
203,354
Foreign currency exchange differences
6,677
Total other income (expense)
244,368
Loss before income taxes
-869,496
Net loss
-869,496
Unrealized foreign currency translation (loss) gain
37,072
Comprehensive loss
-832,424
Basic EPS
-0.47
Diluted EPS
-0.47
Basic Average Shares
1,849,389
Diluted Average Shares
1,849,389
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Comprehensive loss
-$832,424
Unrealized foreign
currency translation...
$37,072
Net loss
-$869,496
Change in fair value of
derivative liabilities
$203,354
Interest
expenses/amortization of discount
$34,337
Foreign currency
exchange differences
$6,677
Loss before income
taxes
-$869,496
Total other income
(expense)
$244,368
Loss from operations
-$1,113,864
Total operating
expenses
$1,113,864
Salaries and wages
$340,030
Research and development
$273,229
General and
administrative - other
$159,915
Accounting and audit fees
$145,579
Legal fees
$121,868
Consulting fees
$73,243
Buy us a coffee
Protagenic Therapeutics, Inc. new (PTIXW)
Protagenic Therapeutics, Inc. new (PTIXW)